MeSH tree: C14.280.238.625
A multicenter study coordinated by the University Hospital Bonn (UKB) involving 26 European centers provides new insights into the course of the disease, prognosis assessment, and risk factors for severe myocarditis. The ...
Sep 11, 2025
0
12
On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine policies.
Sep 4, 2025
0
15
New ESC Guidelines to improve the diagnosis and care of patients with myocarditis and pericarditis have been published at ESC Congress 2025 and also appear in the European Heart Journal.
Aug 29, 2025
0
21
Vaccination with the updated COVID-19 mRNA vaccine containing the severe acute respiratory syndrome coronavirus-2 omicron JN.1 lineage was not associated with an increased risk for 29 adverse events, according to a study ...
Aug 6, 2025
0
17
A new ESC Clinical Consensus Statement published in the European Heart Journal discusses the key role of vaccination in preventing cardiovascular events following various viral and bacterial infections.
Jun 30, 2025
0
17
The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.
Jun 27, 2025
0
17
New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint inhibitors.
Jun 20, 2025
0
15
The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses is the latest blow to national defense, former health security officials said. They warned ...
Jun 11, 2025
0
16
The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.
May 22, 2025
0
61
U.S. regulators will no longer approve COVID booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
May 20, 2025
0
18
